Prospective assessment of two-stage testing for Clostridium difficile

Journal of Hospital Infection

Volumn 76, Issue 1, 2010, Pages 18-22

  Arnold, A ^a   Pope, C ^a   Bray, S ^a   Riley, P ^a,b   Breathnach, A ^a,b   Krishna, S ^b   Planche, T ^a,b  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Clostridium difficile infection; Diagnosis; Immunoassay

Indexed keywords

AGED; ARTICLE; BACTERIUM CULTURE; CELL ASSAY; CELL CYTOTOXICITY ASSAY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; FECES ANALYSIS; HUMAN; NONHUMAN; TOXIGENIC CULTURE;

EID: 77955513142     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.03.018     Document Type: Article

References (16)

1. Health Protection Agency Clostridium difficile infection: how to deal with the problem 2008, HPA, London.
2. George W.L., Sutter V.L., Citron D., Finegold S.M. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 1979, 9:214-219.
3. Lemee L., Dhalluin A., Testelin S., et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 2004, 42:5710-5714.
4. Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002, 346:334-339.
5. Poutanen S.M., Simor A.E. Clostridium difficile-associated diarrhea in adults. Can Med Assoc J 2004, 171:51-58.
6. Bartlett J.G., Gerding D.N. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008, 46(Suppl. 1):S12-18.
7. Planche T., Aghaizu A., Holliman R., et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008, 8:777-784.
8. Ticehurst J.R., Aird D.Z., Dam L.M., et al. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006, 44:1145-1149.
9. Wilcox M.H., Eastwood K.A. CEP08054: evaluation report. Clostridium difficile toxin detection assays 2009, Centre for Evidence-Based Purchasing, London.
10. Barbut F., Braun M., Burghoffer B., Lalande V., Eckert C. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol 2009, 47:1276-1277.
11. Sloan L.M., Duresko B.J., Gustafson D.R., Rosenblatt J.E. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 2008, 46:1996-2001.
12. Vanpoucke H., De Baere T., Claeys G., Vaneechoutte M., Verschraegen G. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens. Clin Microbiol Infect 2001, 7:55-64.
13. Gerding D.N., Olson M.M., Peterson L.R., et al. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med 1986, 146:95-100.
14. Peterson L.R., Olson M.M., Shanholtzer C.J., Gerding D.N. Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea. Diagn Microbiol Infect Dis 1988, 10:85-91.
15. Shanholtzer C.J., Willard K.E., Holter J.J., Olson M.M., Gerding D.N., Peterson L.R. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol 1992, 30:1837-1840.
16. Kelly M.T., Champagne S.G., Sherlock C.H., Noble M.A., Freeman H.J., Smith J.A. Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea. J Clin Microbiol 1987, 25:1244-1247.